BioForce Nanosciences Holdings Inc. (“BioForce or the “Company”) was previously in the business of manufacturing nano-particular measurement devices and molecular printers, but due to a lack of profitability, the subsidiary of the company that owned that technology filed for bankruptcy. That subsidiary and related technology was later bought out of bankruptcy by an unrelated third party. Subsequently, new management came into the Company to pursue a better business model and now the Company’s mission is to become a leading provider of natural vitamins, minerals and other nutritional supplements, powders and beverages, formulated to promote a healthier lifestyle for active individuals in all age ranges. The Company private labels products with key distributors and manufacturing providers.
Company profile
Ticker
BFNH
Exchange
Website
CEO
Merle Ferguson
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
SILVER RIVER VENTURES, INC.
SEC CIK
Corporate docs
IRS number
743078125
BFNH stock data
Latest filings (excl ownership)
8-K
Changes in Registrant's Certifying Accountant
7 May 24
10-Q
2024 Q1
Quarterly report
3 May 24
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
27 Jul 22
Latest ownership filings
4
Merle Ferguson
18 Oct 23
4
Merle Ferguson
18 Oct 23
4
Merle Ferguson
14 Dec 22
4
Merle Ferguson
3 Oct 22
4/A
RICHARD KAISER KAISER
9 Dec 20
4/A
Merle Ferguson
9 Dec 20
4/A
RICHARD KAISER KAISER
9 Dec 20
4/A
RICHARD KAISER KAISER
7 Dec 20
4/A
Merle Ferguson
7 Dec 20
4
RICHARD KAISER KAISER
7 Dec 20
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 686.00 | 686.00 | 686.00 | 686.00 | 686.00 | 686.00 |
Cash burn (monthly) | (no burn) | 5.33 | 37.87 k | 39.36 k | 2.64 k | 4.09 k |
Cash used (since last report) | n/a | 38.78 | 275.34 k | 286.16 k | 19.19 k | 29.72 k |
Cash remaining | n/a | 647.22 | -274.65 k | -285.47 k | -18.50 k | -29.03 k |
Runway (months of cash) | n/a | 121.4 | -7.3 | -7.3 | -7.0 | -7.1 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Oct 23 | Ferguson Merle | Common Stock | Gift | Acquire G | No | No | 0 | 1,400,000 | 0.00 | 17,870,000 |
17 Oct 23 | Ferguson Merle | Common Stock | Gift | Acquire G | No | No | 0 | 1,470,000 | 0.00 | 16,470,000 |
17 Oct 23 | Ferguson Merle | Common Stock | Gift | Dispose G | Yes | No | 0 | 1,470,000 | 0.00 | 15,000,000 |
12 May 23 | Ferguson Merle | Common Stock | Gift | Dispose G | Yes | No | 0 | 500,000 | 0.00 | 16,470,000 |
13 Dec 22 | Ferguson Merle | Common Stock | Gift | Dispose G | Yes | No | 0 | 20,000 | 0.00 | 16,970,000 |